Precision Optics Reports First Quarter Fiscal 2027 Financial Results

Conference Call Scheduled for Today, November 16, at 5:00 p.m. ET


LITTLETON, Mass., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced financial results for its first quarter of fiscal 2027 ended September 30, 2026.

Q1 2027 Financial Highlights (3 Months Ended September 30, 2026)

  • Revenue increased 22% to $8.2 million from $6.7 million in the prior-year fiscal first quarter.
  • Production revenue grew 23% to $7.4 million from $6.0 million in the prior fiscal year quarter.
  • Engineering design services revenue increased 11% year over year to $728,000.
  • Gross margin increased to 22.5% from 14.2% in the prior-fiscal year first quarter.
  • Net loss narrowed to $475,000, or $0.04 per share, from $1.6 million, or $0.21 per share, in the first quarter of the prior fiscal year.
  • Adjusted EBITDA was approximately $(0.2) million, compared with $(1.2) million in the first quarter of the prior fiscal year.
  • Cash and cash equivalents were $9.0 million at September 30, 2026 compared with $9.8 million at June 30, 2026.

Recent Operating Highlights

  • Generated $2.3 million in revenue during the first quarter of fiscal 2027 from the Company’s established satellite optical communications program. After quarter-end, the Company received a follow-on production order from the same top-tier aerospace customer, which was earlier than anticipated.
  • Received a follow-on engineering order from a U.S. space technology company developing a new satellite constellation.
  • Generated approximately $1.8 million in production revenue during the first quarter of fiscal 2027 from the single-use cystoscope program.
  • Achieved revenue of $581,000 during the first quarter of fiscal 2027 from the single-use ophthalmic program as shipments increased under the $3.5 million follow-on order.
  • Received a $1.3 million follow-on production order from a large defense company with production that commenced in October 2026.

Fiscal 2027 Financial Outlook

The Company maintains its expectation for fiscal year 2027 revenue to be in the range of $30 million to $33 million and for Adjusted EBITDA to be in a range of $(1.2) million to $(1.7) million.

“Revenue grew 22% year over year to $8.2 million, led by a 23% increase in production revenue. Higher volumes and more efficient manufacturing helped lift gross margin and improved our Adjusted EBITDA,” said Dr. Joe Forkey, CEO of Precision Optics. “Our established satellite optical communications program generated $2.3 million in first-quarter revenue, and the same customer placed a $2 million follow-on production order after quarter-end, earlier than we anticipated. Satellite communications are becoming an increasingly key market for us following the receipt of a follow-on engineering order from a second U.S. space technology customer to support the design of its new satellite constellation.”

“We continued to make operational progress with our single-use medical device programs. The cystoscope program generated $1.8 million in production revenue, and our ophthalmic program delivered revenue of $581,000, as shipments increased under its $3.5 million follow-on order.”

The following table summarizes the unaudited results for the three months ended September 30, 2026 and 2025

  Three Months
  Ended September 30
   2026  2025 
Revenues $8,152,083  $6,680,823 
    
Gross Profit 1,837,851  946,358 
    
Stock Compensation Expenses 229,278  301,639 
Other 2,126,882  2,239,974 
Total Operating Expenses 2,356,161  2,541,613 
    
Operating Income (Loss) (518,310) (1,595,255)
    
Net Income (Loss) (474,854) (1,637,030)
    
Income (Loss) per Share  
 Basic & Fully Diluted $(0.04) $(0.21)
    
   
Weighted Average Common Shares Outstanding
 Basic & Fully Diluted 10,974,771  7,714,701 
    

Conference Call Details

Monday, November 16, 2026, at 5:00 p.m. ET. Participants may dial 1-844-735-3662 (U.S. and Canada) or 1-412-317-5705 (international).

Live webcast and webcast replay: https://app.webinar.net/7KDE27PWeyo.

A telephone replay will be available through November 23 at 1-855-669-9658 (U.S. and Canada) or 1-412-317-0088 (international). The replay access code is 7453200.

About Precision Optics Corporation

Founded in 1982, Precision Optics is a vertically integrated optics company focused on leveraging its proprietary micro-optics, multi-channel and ultra-high precision imaging and digital imaging technologies across the medical device, defense/aerospace and satellite communications markets. Through its Systems Manufacturing, Engineering, Ross Optical and Micro-Optics Lab operations, the Company provides services from new product concept and design through volume production. Its in-house optical, mechanical, electrical and systems engineering, prototyping, regulatory support, fabrication, assembly and manufacturing capabilities enable it to develop next-generation solutions for demanding customer requirements. In medical devices, Precision Optics supports minimally invasive and robotic surgery with micro-endoscopes, single-use and reusable endoscopes, digital imaging and related optical assemblies. In defense/aerospace and satellite communications, the Company applies its micro-optics and opto-mechanical expertise to applications requiring high quality and optimized size, weight and power. Ross Optical complements these capabilities through global sourcing, inspection and production of custom and catalog optics. For more information, please visit www.poci.com.

Non-GAAP Financial Measures

Precision Optics has provided in this press release financial information that has not been prepared in accordance with accounting principles generally accepted in the United States of America (“non-GAAP”). The non-GAAP financial measure is Adjusted EBITDA (earnings before interest, taxes, depreciation and amortization). In addition to these items, Adjusted EBITDA excludes from Net Income (Loss) the effect of stock-based compensation.

This non-GAAP financial measure assists Precision Optics management in comparing its operating performance over time because certain items may obscure the underlying business trends and make comparisons of long-term performance difficult, as they are of a nature and/or size that occur with inconsistent frequency or relate to discrete acquisition or restructuring plans that are fundamentally different from the ongoing productivity of the Company. Precision Optics management also believes that presenting this measure allows investors to view its performance using the same measures that the Company uses in evaluating its financial and business performance and trends.

Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information calculated in accordance with GAAP. Investors are encouraged to review the reconciliation of non-GAAP measures to their most directly comparable GAAP financial measures. A reconciliation of the non-GAAP financial measure presented above to GAAP results has been provided in the financial tables included with this press release.

Precision Optics is unable to provide a reconciliation of forward-looking Adjusted EBITDA guidance to net income (loss), the most directly comparable GAAP financial measure, without unreasonable efforts because of the inherent difficulty in forecasting and quantifying certain amounts that are necessary for such reconciliation, including stock-based compensation expense, which may vary significantly based on stock price and other factors outside the Company’s control. The unavailable information could have a significant effect on the Company’s GAAP financial results.

About Forward-Looking Statements

This press release contains forward-looking statements within the meaning of U.S. federal securities laws, including statements concerning our fiscal year 2027 revenue and Adjusted EBITDA guidance, as well as the timing and expectations for certain production orders. Any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements. In addition, any statements that refer to projections, forecasts, or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intends," "may," "might," "plan," "possible," "potential," "predict," "project," "should," "would" and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. The forward-looking statements contained in this press release are based on certain assumptions and analyses made by the management of the Company in light of their respective experience and perception of historical trends, current conditions, and expected future developments and their potential effects on the Company as well as other factors they believe are appropriate in the circumstances. There can be no assurance that future developments affecting the Company will be those anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond the control of the Company), or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements, including the demand for the Company's products, global supply chains and economic activity in general and other risks and uncertainties identified in the Company's filings with the SEC. Should one or more of these risks or uncertainties materialize or should any of the assumptions being made prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required under applicable securities laws.

Investor Contact:
Robert Blum
Lytham Partners, LLC
602-889-9700
poci@lythampartners.com

PRECISION OPTICS CORPORATION, INC.
BALANCE SHEETS
(UNAUDITED)
       
  September 30,  June 30, 
  2026  2026 
ASSETS        
Current Assets:        
Cash and cash equivalents $8,966,889  $9,841,142 
Accounts receivable, net of allowance for credit losses of $109,055 at September 30, 2026 and $108,220 at June 30, 2026  5,371,290   5,944,412 
Inventories, net  3,518,893   3,829,414 
Prepaid expenses  586,022   494,488 
Total current assets  18,443,094   20,109,456 
         
Fixed Assets:        
Machinery and equipment  3,427,461   3,410,813 
Leasehold improvements  1,226,171   1,226,171 
Furniture and fixtures  674,445   645,046 
   5,328,077   5,282,030 
Less—accumulated depreciation and amortization  4,415,080   4,394,317 
Net fixed assets  912,997   887,713 
         
Operating lease right-of-use asset  2,229,155   2,300,866 
Patents, net  206,597   212,889 
Goodwill  8,824,210   8,824,210 
Total other assets  11,259,962   11,337,965 
TOTAL ASSETS $30,616,053  $32,335,134 
         
LIABILITIES AND STOCKHOLDERS’ EQUITY        
Current Liabilities:        
Current maturities of long-term debt $577,898  $577,898 
Accounts payable  2,620,358   3,582,674 
Customer advances  2,342,890   2,498,501 
Accrued compensation and other  1,619,014   1,843,368 
Current portion of operating lease liability  335,011   325,500 
Total current liabilities  7,495,171   8,827,941 
         
Long-term debt, net of current maturities  562,023   711,305 
Operating lease liability, net of current portion  2,358,873   2,446,576 
Total liabilities  10,416,067   11,985,822 
         
Stockholders’ Equity:        
Common stock, $0.01 par value: 50,000,000 shares authorized; issued and outstanding – 10,994,430 shares at September 30, 2026 and 10,972,792 at June 30, 2026  109,944   109,728 
Additional paid-in capital  81,165,417   80,840,105 
Accumulated deficit  (61,075,375)  (60,600,521)
Total stockholders’ equity  20,199,986   20,349,312 
         
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $30,616,053  $32,335,134 


PRECISION OPTICS CORPORATION, INC.
STATEMENTS OF OPERATIONS
FOR THE THREE MONTHS ENDED
SEPTEMBER 30, 2026 AND 2025
(UNAUDITED)
       
  Three Months
Ended September 30,
 
  2026  2025 
Revenues $8,152,083  $6,680,823 
         
Cost of Goods Sold  6,314,232   5,734,465 
Gross Profit  1,837,851   946,358 
         
Research and Development Expenses  306,215   311,840 
Selling, General and Administrative Expenses  2,049,946   2,229,773 
Total Operating Expenses  2,356,161   2,541,613 
         
Operating Loss  (518,310)  (1,595,255)
         
Other income (expense):        
Interest expense  (30,121)  (41,775)
Interest income  73,577   – 
         
Net Loss $(474,854) $(1,637,030)
         
Loss Per Share:        
Basic & Fully Diluted $(0.04) $(0.21)
         
Weighted Average Common Shares Outstanding:        
Basic & Fully Diluted  10,974,771   7,714,701 


PRECISION OPTICS CORPORATION, INC.
STATEMENTS OF STOCKHOLDERS’ EQUITY
FOR THE THREE MONTHS ENDED
SEPTEMBER 30, 2026 AND 2025
(UNAUDITED)
                
  Three Month Period Ended September 30, 2026 
  Number of
Shares
  Common
Stock
  Additional
Paid-in
Capital
  Accumulated
Deficit
  Total
Stockholders’
Equity
 
                
Balance, July 1, 2026  10,972,792  $109,728  $80,840,105  $(60,600,521) $20,349,312 
Issuance of common stock for consulting services and employees  21,638   216   96,034   –   96,250 
Stock-based compensation  –   –   229,278   –   229,278 
Net loss  –   –   –   (474,854)  (474,854)
Balance, September 30, 2026  10,994,430  $109,944  $81,165,417  $(61,075,375) $20,199,986 


  Three Month Period Ended September 30, 2025 
  Number of
Shares
  Common
Stock
  Additional
Paid-in
Capital
  Accumulated
Deficit
  Total
Stockholders’
Equity
 
                
Balance, July 1, 2025  7,714,701  $77,147  $69,152,317  $(56,970,630) $12,258,834 
Stock-based compensation  –   –   301,639   –   301,639 
Net loss  –   –   –   (1,637,030)  (1,637,030)
Balance, September 30, 2025  7,714,701  $77,147  $69,453,956  $(58,607,660) $10,923,443 

  

PRECISION OPTICS CORPORATION, INC.
STATEMENTS OF CASH FLOWS
FOR THE THREE MONTHS ENDED
SEPTEMBER 30, 2026 AND 2025
(UNAUDITED)
      
  Three Months
Ended September 30,
 
  2026
 2025 
Cash Flows from Operating Activities:       
Net Loss $(474,854) $(1,637,030)
Adjustments to reconcile net loss to net cash used in operating activities -       
Depreciation and amortization  65,271   65,181 
Stock-based compensation expense  235,528   301,639 
Non-cash interest expense  4,801   4,608 
Non-cash operating lease expense  (6,481)  49,322 
(Gain) Loss on disposal of fixed assets  (36,238)  34,506 
Changes in operating assets and liabilities -       
Accounts receivable, net  573,122   148,797 
Inventories, net  310,521   (318,196)
Prepaid expenses  (91,534)  (14,240)
Accounts payable  (962,316)  1,099,235 
Contract liabilities  (155,611)  208,843 
Accrued compensation and other  (134,354)  135,562 
Net cash provided by (used in) operating activities  (672,145)  78,227 
        
Cash Flows from Investing Activities:       
Purchases of fixed assets  (84,263)  (304,731)
Proceeds from sale of fixed assets  36,238   3,000 
Additional patent costs  –   (58)
Net cash used in investing activities  (48,025)  (301,789)
        
Cash Flows from Financing Activities:       
Payments of capital lease obligations  –   (8,985)
Payments of debt issuance costs  (5,000)  – 
Payments of long-term debt  (149,083)  (149,083)
Net cash used in financing activities  (154,083)  (158,068)
        
Net decrease in cash and cash equivalents  (874,253)  (381,630)
Cash and cash equivalents, beginning of period  9,841,142   1,773,735 
        
Cash and cash equivalents, end of period $8,966,889  $1,392,105 
        
Supplemental disclosure of cash flow information:       
Cash paid during the period for income taxes $–  $2,600 
Cash paid during the period for interest $25,320  $37,167 
Issuance of common stock for employee services $96,250  $– 
Operating right-of-use assets obtained in exchange for operating lease liabilities $–  $2,632,584 
Lease improvements financed by landlord $–  $218,750 


PRECISION OPTICS CORPORATION, INC.
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
ADJUSTED EBITDA
  
  Three Months Ended  
30-Sep 
  2026
  2025
 
Net Income (loss) (GAAP) $(474,854)  $(1,637,030) 
         
Stock based compensation  229,278    301,639  
         
Depreciation and amortization  65,271    65,181  
         
Interest Expense  30,121    41,775  
         
Interest Income  (73,577)   -  
         
Adjusted EBITDA (non-GAAP) $(223,761)  $(1,228,435) 



GlobeNewswire